Histoplasmosis: a review for clinicians from non-endemic areas.

Histoplasmosis is an important systemic mycosis in the Americas, Asia, and Africa. Increasingly cases are recognised in nonendemic areas. Proper management requires recognition of the clinical syndromes caused by Histoplasma capsulatum infection, familiarity with the uses and limitations of the diagnostic tests, an understanding of the indications for treatment and role of specific antifungal agents. This review will address these issues with the goal of providing physicians in non-endemic areas sufficient information to suspect, diagnose, and treat patients with histoplasmosis.

[1]  S. Antinori,et al.  Histoplasmosis Among Human Immunodeficiency Virus-Infected People in Europe: Report of 4 Cases and Review of the Literature , 2006, Medicine.

[2]  S. Holland,et al.  Disseminated Histoplasmosis in Persons with Interferon-γ Receptor 1 Deficiency , 2005 .

[3]  M. Broder,et al.  Reactivation of latent granulomatous infections by infliximab. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  E. García-Vázquez,et al.  Infección por Histoplasma capsulatum en un grupo de cooperantes en Guatemala , 2005 .

[5]  C. E. Musial,et al.  Diagnosis and management of central nervous system histoplasmosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  A. Mazzoni,et al.  Histoplasmosis in Europe , 1970, Mycopathologia et mycologia applicata.

[7]  P. Connolly,et al.  Antigen Assay with the Potential To Aid in Diagnosis of Blastomycosis , 2004, Journal of Clinical Microbiology.

[8]  M. Harper,et al.  Disseminated histoplasmosis in a nonendemic area. , 2004, The Pediatric infectious disease journal.

[9]  C. Yiannoutsos,et al.  Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  L. Wheat,et al.  Pulmonary Histoplasmosis Syndromes: Recognition, Diagnosis, and Management , 2004, Seminars in respiratory and critical care medicine.

[11]  G. Lyon,et al.  Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999. , 2004, The American journal of tropical medicine and hygiene.

[12]  F. Dromer,et al.  An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West Indies. , 2006, Journal of travel medicine.

[13]  L. Wheat.  Current diagnosis of histoplasmosis. , 2003 .

[14]  J. Girardini,et al.  Molecular Detection of Histoplasma capsulatum var. capsulatum in Human Clinical Samples , 2003, Journal of Clinical Microbiology.

[15]  L. Reller,et al.  Identification of Histoplasmacapsulatum from Culture Extracts by Real-Time PCR , 2003, Journal of Clinical Microbiology.

[16]  K. Cornetta,et al.  Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[17]  D. Bamberger,et al.  Safety and Efficacy of Liposomal Amphotericin B Compared with Conventional Amphotericin B for Induction Therapy of Histoplasmosis in Patients with AIDS , 2002, Annals of Internal Medicine.

[18]  J. Knobloch,et al.  Evaluation of Two Nested PCR Assays for Detection of Histoplasma capsulatum DNA in Human Tissue , 2002, Journal of Clinical Microbiology.

[19]  R. Hafner,et al.  Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  T. Ciulla,et al.  Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies , 2001, Current opinion in ophthalmology.

[21]  L. Wheat,et al.  Treatment of histoplasmosis. , 2001, Seminars in respiratory infections.

[22]  J. Ayuso,et al.  Imported histoplasmosis in Spain. , 2006, Journal of travel medicine.

[23]  J. M. Torres-Rodríguez,et al.  [Diagnostic usefulness of the intradermal test with histoplamin in non-endemic areas of histoplasmosis]. , 2000, Revista iberoamericana de micologia.

[24]  M. Mcginnis,et al.  In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis,Coccidioides immitis, and Histoplasma capsulatum , 2000, Antimicrobial Agents and Chemotherapy.

[25]  G. Sarosi,et al.  Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  H. Kohli,et al.  Disseminated histoplasmosis 19 years after renal transplantation. , 1999, Clinical nephrology.

[27]  D. Loebenberg,et al.  Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice , 1999, Antimicrobial Agents and Chemotherapy.

[28]  U. Eichfeld,et al.  Inflammatorischer Pseudotumor der Lunge bei Hiluslymphknotenhistoplasmose , 1998, Der Chirurg.

[29]  A. Espinel-Ingroff.  Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts , 1998, Journal of Clinical Microbiology.

[30]  M. Cusini,et al.  Disseminated histoplasmosis presenting with cutaneous lesions in a patient with acquired immunodeficiency syndrome. , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[31]  H. Gugnani,et al.  African histoplasmosis: a review. , 1997, Revista iberoamericana de micologia.

[32]  M. Saag,et al.  Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. , 1997, The American journal of medicine.

[33]  R. Kirsner,et al.  Cutaneous disseminated histoplasmosis in AIDS patients in south Florida , 1997, International journal of dermatology.

[34]  P. Connolly,et al.  Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  C. Armbruster,et al.  [Acute pulmonary histoplasmosis with liver and lung involvement outside the endemic area--differential diagnosis]. , 1996, Wiener klinische Wochenschrift.

[36]  W. Rozenbaum,et al.  Intestinal histoplasmosis in AIDS patients: report of three cases observed in France and review of the literature. , 1995, European journal of gastroenterology & hepatology.

[37]  L. Wheat,et al.  Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. , 1992, The American review of respiratory disease.

[38]  B. Katz,et al.  Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. , 1991, Annals of internal medicine.

[39]  M. Zeckel,et al.  Disseminated Histoplasmosis in the Acquired Immune Deficiency Syndrome: Clinical Findings, Diagnosis and Treatment, and Review of the Literature , 1990, Medicine.

[40]  H. Sakellaris,et al.  A Serendipitous Isolate of Histoplasma Capsulatum , 1988, Pathology.

[41]  C. Payá,et al.  Transient fungemia in acute pulmonary histoplasmosis: detection by new blood-culturing techniques. , 1987, Journal of Infectious Diseases.

[42]  T. Slama,et al.  Clinical and Laboratory Features of Disseminated Histoplasmosis During Two Large Urban Outbreaks , 1983, Medicine.

[43]  K. Brandt,et al.  Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic. , 1983, Arthritis and rheumatism.

[44]  T. Slama,et al.  Pericarditis as a Manifestation of Histoplasmosis during Two Large Urban Outbreaks , 1983, Medicine.

[45]  J. Loyd,et al.  Histoplasmosis in normal hosts. , 1981, Medicine.

[46]  T. Slama,et al.  A large urban outbreak of histoplasmosis: clinical features. , 1981, Annals of internal medicine.

[47]  R. D. Des Prez,et al.  Disseminated histoplasmosis: clinical and pathologic correlations. , 1980, Medicine.

[48]  G. Sarosi,et al.  Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. , 1978, The American journal of medicine.

[49]  C. Smith,et al.  Supportive evidence by field testing and laboratory experiment for a new hypothesis of the ecology and pathogenicity of canine blastomycosis. , 1974, Sabouraudia.

[50]  B. Schwartz,et al.  Histoplasmosis in non-endemic regions. , 1953, The American journal of medicine.